The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

N.Yu. Pylaeva

Vernadsky Crimean Federal University

E.M. Shifman

Moscow Regional Research and Clinical Institute

E.G. Ponomareva

Semashko Republican Clinical Hospital

E.S. Osmanova

Semashko Republican Clinical Hospital

Antithrombin III — evolution from anticoagulant to a marker of severe preeclampsia


N.Yu. Pylaeva, E.M. Shifman, E.G. Ponomareva, E.S. Osmanova

More about the authors

Views: 2489

Downloaded: 94

To cite this article:

Pylaeva NYu, Shifman EM, Ponomareva EG, Osmanova ES. Antithrombin III — evolution from anticoagulant to a marker of severe preeclampsia. Russian Journal of Anesthesiology and Reanimatology. 2020;(6):57‑61. (In Russ.)

Recommended articles:
Epilepsy surgery in children with tube­rous scle­rosis. Burdenko's Journal of Neurosurgery. 2023;(2):5-16
Predictors of slowing down the wound healing in overweight patients. Plastic Surgery and Aesthetic Medi­cine. 2023;(2):42-46
Pancreaticoduodenectomy — resu­lts and prospects (two-center study). Piro­gov Russian Journal of Surgery. 2023;(5):13-21
The influence of uric acid on the course of amyotrophic late­ral scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(5):177-180
Features of surgical patients of COVID-19 patients. Piro­gov Russian Journal of Surgery. 2023;(7):51-56

Email Confirmation

An email was sent to with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.